Fawzy AM, Rivera-Caravaca JM, Underhill P, Fauchier L, et al. Incident heart failure, arrhythmias and cardiovascular outcomes with sodium glucose co-transporter 2 (SGLT2) inhibitor use in diabetic patients: Insights from a global federated electronic medical record database. Diabetes Obes Metab 2022 Aug 31. doi: 10.1111/dom.14854.
PMID: 36054168